Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30574285 | 1.00 | KCNH2 (0.36) | KCNH2CA12CA1CA2CA4 | |
| SCHEMBL1837567 | 0.88 | CYP3A4 (0.41) | KCNH2CA12CA1CA2CA4 | |
| SCHEMBL2153874 | 0.84 | KCNH2 (0.35) | KCNH2CA12CA1CA2CA4 | |
| SCHEMBL2153865 | 0.83 | KCNH2 (0.34) | KCNH2CA12CA1CA2CA4 | |
| SCHEMBL29428931 | 0.80 | CA1 (0.45) | KCNH2CA12CA1CA2CA4 | |
| SCHEMBL3820431 | 0.80 | CA1 (0.45) | KCNH2CA12CA1CA2CA4 | |
| SCHEMBL2154131 | 0.78 | KCNH2 (0.32) | KCNH2KDM4EALDH1A1HSD17B10 | |
| SCHEMBL1838651 | 0.77 | GAA (0.37) | KDM4EALDH1A1 | |
| SCHEMBL2155672 | 0.77 | ALDH1A1 (0.33) | KCNH2KDM4EALDH1A1HSD17B10 | |
| SCHEMBL27970886 | 0.74 | RIPK1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3620459-B9 | PHOSPHORUS-CONTAINING PHENOLIC COMPOUND, PHOSPHORUS-CONTAINING EPOXY RESIN, CURABLE RESIN COMPOSITION THEREOF, OR EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2023-10-04 | — | — | EP | disclosed |
| EP-3620459-B1 | PHOSPHORUS-CONTAINING PHENOLIC COMPOUND, PHOSPHORUS-CONTAINING EPOXY RESIN, CURABLE RESIN COMPOSITION THEREOF, OR EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2023-05-24 | — | — | EP | disclosed |
| CN-112694599-A | Phenoxy resin, method for producing same, resin composition thereof, and cured product | 日铁化学材料株式会社 | 2021-04-23 | — | — | CN | disclosed |
| EP-3620459-A1 | PHOSPHORUS-CONTAINING PHENOLIC COMPOUND, PHOSPHORUS-CONTAINING EPOXY RESIN, CURABLE RESIN COMPOSITION THEREOF, OR EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF | NIPPON STEEL Chemical & Material Co., Ltd. (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-2321244-B1 | IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-1788014-B1 | Thermosensitive adhesive composition, method of manufacturing the same and thermosensitive adhesive article | RICOH CO LTD (JP) | 2016-03-09 | — | — | EP | disclosed |
| US-8558030-B2 | Process for telomerization of butadiene | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-10-15 | — | — | US | disclosed |
| US-7989529-B2 | Thermosensitive adhesive composition, method of manufacturing the same and thermosensitive adhesive material | RICOH COMPANY, LTD. (JP) | 2011-08-02 | — | — | US | disclosed |
| US-20110137086-A1 | PROCESS FOR TELOMERIZATION OF BUTADIENE | Dow Global Technologies LLC (Formerly known as Dow Global Technologies Inc.) (US) | 2011-06-09 | — | — | US | disclosed |
| EP-2321244-A2 | AN IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE | Dow Global Technologies LLC (US) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010019360-A2 | AN IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-02-18 | — | — | WO | disclosed |
| EP-1788014-A1 | Thermosensitive adhesive composition, method of manufacturing the same and thermosensitive adhesive article | Ricoh Company, Ltd. (JP) | 2007-05-23 | — | — | EP | disclosed |
| US-20070112113-A1 | Thermosensitive adhesive composition, method of manufacturing the same and thermosensitive adhesive material | RICOH COMPANY, LTD. | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137086-A1 | PROCESS FOR TELOMERIZATION OF BUTADIENE | HRH3, HRH4, TELO2 | KCNH2 4513/4885CA12 4195/4885CA1 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.